Adoption of evidence-informed guidelines in prescribing protease inhibitors for HIV-Tuberculosis co-infected patients on rifampicin and effects on HIV treatment outcomes in Uganda

BACKGROUND: We aimed to determine how emerging evidence over the past decade informed how Ugandan HIV clinicians prescribed protease inhibitors (PIs) in HIV patients on rifampicin-based tuberculosis (TB) treatment and how this affected HIV treatment outcomes. METHODS: We reviewed clinical records of...

Descripción completa

Detalles Bibliográficos
Autores principales: Mulindwa, Frank, Castelnuovo, Barbara, Kirenga, Bruce, Kalibbala, Dennis, Haguma, Priscilla, Muddu, Martin, Semitala, Fred C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369708/
https://www.ncbi.nlm.nih.gov/pubmed/34399706
http://dx.doi.org/10.1186/s12879-021-06533-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369708/
https://www.ncbi.nlm.nih.gov/pubmed/34399706
http://dx.doi.org/10.1186/s12879-021-06533-6

Ejemplares similares